PFMU
NGNE icon

Privium Fund Management (UK)’s Neurogene NGNE Stock Holding History

Privium Fund Management (UK)’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,860
Closed -$274K – 177
2024
Q1 		$274K Buy
+5,860
New +$196K 0.14% 74
2023
Q3 		– Sell
-5,860
Closed -$94.9K – 83
2023
Q2 		$94.9K Hold
5,860
– – 0.07% 65
2023
Q1 		$80.3K Hold
5,860
– – 0.06% 61
2022
Q4 		$59.7K Hold
5,860
– – 0.05% 52
2022
Q3 		$75K Buy
+5,860
New +$120K 0.1% 52

Other funds holding NGNE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Privium Fund Management (UK)'s NGNE Position: Q2 2024 in Review

Privium Fund Management (UK) sold out of Neurogene (NGNE) in Q2 2024, closing a stake of 5,860 shares — an estimated $274K sold.

Privium Fund Management (UK) first reported a position in NGNE in Q3 2022 and held it in 5 quarters. The position peaked at $274K in Q1 2024. 66 funds tracked by Wall St. Rank hold NGNE as of Q2 2024.

  • Privium Fund Management (UK) reported no remaining Neurogene position as of Q2 2024 after selling out during the quarter.
  • Privium Fund Management (UK) sold 5,860 Neurogene shares in Q2 2024, an estimated $274K.
  • Privium Fund Management (UK) first reported a position in Neurogene in Q3 2022 and held it in 5 quarters.
  • Privium Fund Management (UK)'s Neurogene position peaked at $274K in Q1 2024.
  • 66 funds tracked by Wall St. Rank held Neurogene as of Q2 2024.

Based on Privium Fund Management (UK)'s 13F filing for Q2 2024, filed 2 Aug 2024.